📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

HCA Healthcare To Buy Large Stake In Galen College Of Nursing

Published 03/17/2019, 11:11 PM
Updated 07/09/2023, 06:31 AM
UNH
-
HCA
-
WCG
-
CNC
-

HCA Healthcare (NYSE:HCA) along with Galen College of Nursing recently announced that the company will become the majority owner of Galen’s parent company. This unique collaboration, which will combine the expertise of both organizations, is expected to improve access to nursing education and provide career development opportunities in the same field. However, the deal is subject to a pending regulatory approval and other customary conditions. Terms of the deal were not disclosed.

HCA Healthcare, one of the major employers of nurses in the country, makes concerted efforts to drive nursing excellence. This, in turn, has led to better clinical outcomes, an enriched patient experience and better nurse engagement. The company believes that Galen with a great reputation for nursing studies is its perfect partner.

Notably, for Galen, the deal is an extension of its focus on nursing and its aim to boost access to good nursing training.

This is yet another step taken by HCA Healthcare’s to live up to its commitment toward being the leading career hub for nurses along with addressing the country’s rising nursing needs.

The company also previously made steadfast efforts to retain its nurses as well. During early 2018, it pledged $300 million for employee benefits by enhancing career development programs to retain and attract nurses. Those consist of tuition reimbursement for most full and part-time staff, student loan debt assistance, expanded certification offerings and plans for a scholarship program for children of HCA Healthcare employees.

In 2018, the company added more than 6,200 registered nurses and invested in advanced technologies to support nursing.

Notably, HCA Healthcare has been emphasizing on acquisitions for expedited growth. Its inorganic growth strategies have led to patient volumes enabled network expansion across several markets and added hospitals to its portfolio. The company’s buyouts are expected to add scale to its business, thus positioning it better to weather the regulatory uncertainties in the healthcare sector. On Feb 1, 2019, the company completed the awaiting integration of Mission Health, a six-hospital system in Asheville and the Western North Carolina for a value of around $1.5 billion. All these initiatives poise the company well for growth.

Shares of this Zacks Rank #3 (Hold) company have rallied 29% in a year’s time, outperforming its industry’s growth of 13.1%.


Stocks to Consider

Investors interested in the medical sector can take a look at some better-ranked stocks like UnitedHealth Group Incorporated (NYSE:UNH) , Centene Corporation (NYSE:CNC) and WellCare Health Plans, Inc. (NYSE:WCG) , each currently carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

UnitedHealth operates as a diversified health care company in the United States. In the last four quarters, the company delivered average beat of 3.39%.

Centene operates as a diversified and multi-national healthcare enterprise in the United States. It came up with average earnings surprise of 4.99% in the trailing four quarters.

WellCare Health offers managed care services to government-sponsored health care programs. The company pulled off average positive surprise of 15.43% in the preceding four quarters.

Is Your Investment Advisor Fumbling Your Financial Future?

See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”

Click to get it free >>



WellCare Health Plans, Inc. (WCG): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

HCA Healthcare, Inc. (HCA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.